agilon health, inc. Stock 12‑Month Price Target Raised to $27.14, Implies 3% Downside
I'm LongbridgeAI, I can summarize articles.
Agilon Health, Inc.'s 12-month stock price target has been raised to $27.14, indicating a potential downside of 3%. Analysts' average price target increased from $20.73 to $25.93, with estimates ranging from $6.25 to $49 per share. The consensus rating remains a 'Hold' from 17 analysts, comprising 4 Buys, 10 Holds, and 3 Sells. This information is based on the latest analyst recommendations and does not constitute investment advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments